2001
DOI: 10.1046/j.1365-2141.2001.02628.x
|View full text |Cite
|
Sign up to set email alerts
|

The hepatologist in the haematologists' camp

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
9
0

Year Published

2002
2002
2018
2018

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 125 publications
1
9
0
Order By: Relevance
“…The role of histology in the clinical management of L‐GVHD is usually limited to selected situations. Liver biopsy is indicated when one or more causes of liver dysfunction other than L‐GVHD are suspected, or when L‐GVHD occurs in isolation without extrahepatic involvement, or when liver dysfunction does not respond to increased immunosuppression following a clinical diagnosis of L‐GVHD 15,16 . The potential value of liver biopsy in L‐GVHD patients is outweighed by the procedure‐related risk and clinical data (e.g.…”
Section: Discussionmentioning
confidence: 99%
“…The role of histology in the clinical management of L‐GVHD is usually limited to selected situations. Liver biopsy is indicated when one or more causes of liver dysfunction other than L‐GVHD are suspected, or when L‐GVHD occurs in isolation without extrahepatic involvement, or when liver dysfunction does not respond to increased immunosuppression following a clinical diagnosis of L‐GVHD 15,16 . The potential value of liver biopsy in L‐GVHD patients is outweighed by the procedure‐related risk and clinical data (e.g.…”
Section: Discussionmentioning
confidence: 99%
“…Sinusoidal obstruction syndrome and drug-induced hepatotoxicity are frequently observed in the first few weeks after SCT. Subsequently, acute GVHD, viral infection, chronic GVHD, and nodular regenerative hyperplasia develop (10). Adenovirus is one of the causes of fulminant hepatic failure after HSCT.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment of patients with a positive PCR for HBV DNA with any of the available agents (interferon-alpha, lamivudine, ganciclovir or famciclovir) has been advocated before stem cell transplantation [15]or chemotherapy for lymphoid malignancies [16]. So probably all chronic HBsAg carriers with detectable HBV DNA about to become immunodepressed should receive primary prophylaxis to prevent reactivation, especially those on steroid treatment or with a negative HBeAg [16], as our patient.…”
Section: Discussionmentioning
confidence: 99%